New Medical Device Launch in Alzheimers Disease (AD)

Zekel Healthcare invests in Healthcare Data technology plus various systems, research, testing to emerging data informed us to design applications mobility, tools for management Alzheimers Disease, Dementia. Health IT imaging, clinical trials working along strategic partnerships to better manage requirements, to meet the multiple agencies efficiently. Following new standard protocol will ensure information technology road mapping, records of research analysis information to help and provide better management patients, caregivers, doctors For individuals with Alzheimer’s disease and dementia a medical device that could spark compelling outcomes even in the very late stages of the disease. Manage stress-induced agitation, stimulate positive interactions, facilitate cognitive function, and coordinate motor movements. In vision our goals with digital media content licensed, cloud computing, multiple platforms, access to data, improving early detention, interactive diagnois methods, across patient population, identifying factors that affect AD progression Alzheimers disease is an irreversible, progressive brain disease, that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. In most people with Alzheimers, symptoms first appear after age 60. There is no cure for the disease, which worsens as it progresses, and eventually leads to death. The key to successful aging is a healthy, common sense lifestyle. The goals are to better manage ones life with technology, working along side doctors, clinical researchers for new medicine that is developed. Maintain brain's capacity to make up for any loss, and let remaining brain cells function with this medical device could help patients and caregivers. Decrease burden patient stress in long term care inside home. Clinical researchers has shared ideas in our development and international collaboration toward progress disease that threatens the health of a nations and is soon expected to become the single largest healthcare expense for many. Today more than 35 million individuals, robbing them of their memory, independence, and ability to think and understand. By 2050, the number of people with AD is expected to exceed 115 million worldwide if nothing is done to slow or prevent the disease. Zekel and team are doing all we can to help now with awareness campaigns, marketing AD awareness, social media, AD videos. We are excited that the launched of our medical devices and apps, licensed content, health IT technology this year ### About Zekel Healthcare a medical device and healthcare data management technology to help Alzheimers, Dementia patients and caregivers. The present study in AD sought to further investigate the effects on memory in patients with AD by making the content and tools for the daily life of an older adult. Test runs have been successful, in tools for planning, implementation, ethical considerations, content resources, Heathcare IT. For more information contact Mauris Griffin, Zekel Healthcare Product Update: E: [email protected] T: 786.565.5558 SM: @zekelhealthcare


The Real Payback of Healthcare Analytics

Tuesday, April 6 | 2pm ET / 11am PT

With the unpredictability of healthcare today, organizations are sharpening their focus on analytics to make more data-informed decisions. Join us for a roundtable session in which thought leaders will discuss how they are maximizing their analytics investments.